https://mededgemea.com/fda-grants-priority-review-for-gsks-bepirovirsen-for-chronic-hepatitis-b/
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B - MedEdge MEA
Apr 28, 2026 - The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis B, following positive Phase III trial results and earlier Breakthrough Therapy...
chronic hepatitis bfdagrantspriorityreview
https://www.thestar.com/sponsored-sections/closing-the-gaps-in-chronic-hepatitis-b-care-in-canada/article_465d2393-c7b1-478f-a083-aaf03d02993d.html
Closing the gaps in chronic hepatitis B care in Canada
Mar 20, 2026 - An estimated quarter million Canadians have chronic hepatitis B, yet many gaps in its diagnosis and care remain.
closing the gapschronic hepatitis b
https://prepguidelines.com.au/introduction/on-demand-prep-is-contraindicated-in-people-with-chronic-hepatitis-b-infection/
On-demand† PrEP is contraindicated in people with chronic hepatitis B infection - PrEP Guidelines
Nov 16, 2021 - BookmarkPRINT AS PDF Of note, the Panel will continue to monitor the data on the efficacy of on-demand† PrEP for MSM who use on-demand† PrEP less frequently...
chronic hepatitis bpreppeople
https://www.jci.org/articles/view/185568
JCI - Toward a better understanding of chronic hepatitis B virus infection
chronic hepatitis bbetter understandingjcitoward
https://www.who.int/publications/i/item/9789240090903
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B...
The 2024 hepatitis B guidelines provide updated evidence-informed recommendations on key priority topics. They prioritize simplified treatment criteria for...
care and treatmentchronic hepatitis bguidelines for